Drug manufacturing

The aim is to develop an effective burn healing drug in a form of ointment and cream. It may also be used for cutaneous wound treatment with different etiology. "Dermafen" possesses a wide range of actions and demonstrates prominent clinical effect.

1. Drug preclinical trial - 12 million AMD
2. Drug clinical trial - 20 million AMD
3. Purchase of modern equipment and reagents - 10 million AMD
4. Synthesis of 2 kg drug raw material and drug production - 3.5 million AMD
5. Purchase of benzocaine and other compounds - 0.5 million AMD
6. Preparing of drug formulary and registration in RA - 3 million AMD

Total - 49 million AMD (USD 102.085)

-

Vigen Topuzyan, Director of the Scientific and Technological Center of Organic and Pharmaceutical Chemistry of NAS RA
E-mail: vtop {[ at ]} web.am
Tel.: (+374 10) 288334